RMTI
Rockwell Medical, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.99
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 69.4M | 69.3M | 101.5M | 83.6M | 72.8M |
| Cost of Revenue | 57.1M | 57.6M | 84.0M | 74.9M | 68.7M |
| Gross Profit | 12.3M | 11.7M | 17.5M | 8.7M | 4.1M |
| Operating Expenses | |||||
| R&D Expense | 40.0K | — | 19.0K | 1.1M | 3.1M |
| SG&A Expense | 16.8M | 16.4B | 16.9M | 14.3M | 17.7M |
| General & Admin Expense | 14.6M | 14.0B | 14.1M | 12.1M | 15.6M |
| Selling & Marketing Expense | 2.2M | 2.4B | 2.7M | 2.1M | 2.1M |
| Other Expenses | — | (16.4B) | — | — | — |
| Total Operating Expenses | 16.8M | 16.4M | 16.9M | 15.4M | 20.9M |
| Cost and Expenses | 73.9M | 73.9M | 100.9M | 90.3M | 89.6M |
| Operating Income (EBIT) | (4.5M) | (4.7M) | 608.0K | (6.7M) | (16.8M) |
| Non-Operating | |||||
| Interest Income | 176.0K | 234.0K | 92.0K | 211.0K | 33.0K |
| Interest Expense | 1.1M | 1.1M | 1.3M | 2.3M | 1.9M |
| Net Interest Income | (958.0K) | (890.0K) | (1.2M) | (2.1M) | (1.9M) |
| Other Non-Op Income/Expense | (561.0K) | (623.0K) | (1.1M) | (1.8M) | (1.9M) |
| Non-Operating Income (excl Interest) | (573.0K) | (501.0K) | (166.0K) | (532.0K) | (37.0K) |
| EBT (Pre-Tax Income) | (5.1M) | (5.3M) | (480.0K) | (8.4M) | (18.7M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (5.1M) | (5.3M) | (480.0K) | (8.4M) | (18.7M) |
| Earnings from Cont. Ops | (5.1M) | (5.3M) | (480.0K) | (8.4M) | (18.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (5.4M) | (5.5M) | (782.0K) | (8.6M) | (18.7M) |
| Per Share | |||||
| Basic EPS | ($1.39) | ($1.50) | ($0.25) | ($3.60) | ($18.90) |
| Diluted EPS | ($1.39) | ($1.50) | ($0.25) | ($3.60) | ($18.90) |
| Revenue Per Share | $17.53 | $19.25 | $32.68 | $35.85 | $73.79 |
| Shares | |||||
| Basic Shares Outstanding | 4.0M | 3.6M | 3.1M | 2.3M | 986684 |
| Diluted Shares Outstanding | 4.0M | 3.6M | 3.1M | 2.3M | 986684 |
| Profitability Metrics | |||||
| EBITDA | (2.3M) | (2.0M) | 3.0M | (4.7M) | (16.2M) |
| D&A | 1.6M | 2.2M | 2.2M | 1.4M | 576.0K |
| EBIT | (4.0M) | (4.2M) | 774.0K | (6.1M) | (16.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026